Answers are grounded in this paper and cite their sources.
Hepatitis A (HAV) continues to be a significant infectious disease in today's world. Although it does not progress to chronic liver disease and in most cases is a self-limited disease, acute HAV will result in life-threatening fulminant liver failure in a minority of patients and varying degrees of morbidity, with social and economic consequences, in the majority. Despite the fact that HAV is entirely preventable by vaccination, travelers from areas of low endemicity to high endemicity still remain at risk. In this article, we review the epidemiology and clinical features of HAV and the efficacy and safety of the currently available HAV vaccines.
No takes yet. Share an insight, caveat, or question.
A 2007 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: